NextPlat (NXPL) Cash from Operations (2010 - 2026)
NextPlat's (NXPL) quarterly Cash from Operations came in at $1.1 million in Q2 2026, up 204.03% year-over-year from $356209.5 in Q2 2025, and up 141.93% quarter-over-quarter from -$2.6 million in Q1 2026.
Analysis
NextPlat (NXPL) Cash from Operations (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Cash from Operations for 15 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 204.03% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was -$4.5 million, a 44.65% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 12.19% from the prior year.
- Cash from Operations was $1.1 million for Q2 2026 at NextPlat, up from -$2.6 million in the prior quarter.
- Over five years, Cash from Operations peaked at $2.3 million in Q2 2024 and troughed at -$4.6 million in Q3 2024.
- A 5-year average of -$1.1 million and a median of -$983347.0 in 2022 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 287.02% in 2024, down 386.69% in 2024.
- Over 5 years, Cash from Operations stood at -$870924.0 in 2022, then surged by 174.75% to $651000.0 in 2023, then slumped by 173.12% to -$476000.0 in 2024, then soared by 36.55% to -$302000.0 in 2025, then soared by 458.61% to $1.1 million in 2026.
- The last three Cash from Operations figures came in at $1.1 million (Q2 2026), -$2.6 million (Q1 2026), and -$302000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 411.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 381.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -9.79 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -21.24 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 670.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 56.67 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -19.79 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 51.32 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 1.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | -2.58 Mn |
| Dec 31, 2025 | -302,000.00 |
| Sep 30, 2025 | -2.73 Mn |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Dec 31, 2024 | -476,000.00 |
| Sep 30, 2024 | -4.61 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | -2.69 Mn |
| Dec 31, 2023 | 651,000.00 |
| Sep 30, 2023 | -947,000.00 |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | -2.07 Mn |
| Dec 31, 2022 | -870,924.00 |
| Sep 30, 2022 | -842,824.00 |
| Jun 30, 2022 | -1.02 Mn |
| Mar 31, 2022 | -868,558.00 |
| Dec 31, 2021 | -1.09 Mn |
| Sep 30, 2021 | -1.73 Mn |